The proposed rule development: sets the limit on the amount of prescription drugs that may be distributed by a retail pharmacy before that pharmacy is required to be permitted by the division; establishes the criteria for determining when distributions between commonly owned, End-Stage Renal Dialysis pharmacies is such that it requires a license from the department; and revises the application forms that permit applicants for virtual prescription drug manufacturers and repackagers must submit.